![Oscient Pharmaceuticals (MM)](/common/images/company/N_OSCID.png)
Oscient Pharmaceuticals (MM) (OSCID)
NASDAQ
The U.S. Food and Drug Administration (FDA) has accepted as complete Oscient Pharmaceuticals Corporation?s (Nasdaq: OSCI) response to the FACTIVE? (gemifloxacin mesylate...
Oscient Pharmaceuticals Corporation?s (Nasdaq: OSCI) Board of Directors has voted to implement a 1-for-8 reverse stock split effective November 15, 2006 at 11:59 PM ET. An...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約